These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4588504)

  • 21. Antinuclear factors. Their determination by immunofluorescence.
    Gheorghiu M; Purice S
    Rom Med Rev; 1970; 14(4):32-5. PubMed ID: 4928683
    [No Abstract]   [Full Text] [Related]  

  • 22. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN; Malaviya AN
    Indian J Med Res; 1976 Jun; 64(6):895-902. PubMed ID: 789235
    [No Abstract]   [Full Text] [Related]  

  • 23. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
    Lüthke K; Conrad K; Frank KH
    Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Negative antinuclear antibodies in disseminated lupus erythematosus. Report of 3 cases].
    González Ortega MA; Santos G; Reyes PA
    Arch Inst Cardiol Mex; 1979; 49(6):1122-9. PubMed ID: 398681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody.
    Benson MD; Cohen AS
    Ann Intern Med; 1970 Dec; 73(6):943-9. PubMed ID: 4947942
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibodies against ds-DNA in systemic lupus erythematosus--value for diagnosis and determination of activity].
    Geissler K; Graninger W
    Immun Infekt; 1986 May; 14(3):119-20. PubMed ID: 3519437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of immunoenzymatic technics to the assay of anti-native DNA antibodies in the biological diagnosis of lupus erythematosus disseminatus].
    Laplanche S; Diemert MC; Musset L; Abuaf N; Galli J
    Ann Biol Clin (Paris); 1990; 48(3):177-81. PubMed ID: 2191610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Routine immunofluorescence examinations for the demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:150-1. PubMed ID: 4918616
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunofluorescence examination of blood, clinically unchanged skin, and kidneys in systemic lupus erythematosus].
    Stefanović Z; Stefanović M; Arnerić S; Mijailović B
    Zb Vojnomed Akad; 1975; ():18-21. PubMed ID: 801693
    [No Abstract]   [Full Text] [Related]  

  • 30. Lupus erythematosus cell preparation-antinuclear factor incongruity. A review of diagnostic tests for systemic lupus erythematosus.
    Koller SR; Johnston CL; Moncure CW
    Am J Clin Pathol; 1976 Sep; 66(3):495-505. PubMed ID: 60880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti nuclear factors in systemic lupus erythematosus.
    Boonpucknavig S; Pornpathkul M; Kruatrachue M
    J Med Assoc Thai; 1971 Feb; 54(2):98-104. PubMed ID: 4931420
    [No Abstract]   [Full Text] [Related]  

  • 32. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 34. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 35. Antinuclear antibodies in lupus erythematosus.
    Burnham GK
    Arch Dermatol; 1976 Sep; 112(9):1329. PubMed ID: 793525
    [No Abstract]   [Full Text] [Related]  

  • 36. Antinuclear antibodies in the diagnosis of systemic lupus erythematosus.
    Brandstetter RD
    JAMA; 1979 Feb; 241(8):792. PubMed ID: 310897
    [No Abstract]   [Full Text] [Related]  

  • 37. [The direct immunofluorescence skin test in systemic lupus erythematosus. Correlation with the clinical stage of the disease, laboratory changes and nephropathy].
    dos Santos RF; Santiago MB; Yoshinari NH; Rodrigues CJ; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):197-200. PubMed ID: 3074450
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 39. Double stranded DNA antibody quantification by the FARR assay and indirect immunofluorescence test using Crithidia lucilae.
    Graafland HF; Wagner AL
    Int J Nucl Med Biol; 1982; 9(2):114-7. PubMed ID: 7049985
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].
    Kostadinova DA; Razboĭnikov S
    Vutr Boles; 1976; 15(2):18-26. PubMed ID: 59467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.